TY - JOUR
T1 - Lifestyle counseling for medication adherence in glaucoma
AU - Kim, Sandy
AU - Tong, Betty
AU - Lee, Jessica
AU - Borodge, Darara
AU - Kooner, Karanjit
N1 - Funding Information:
Supported in part by an unrestricted grant from the Research to Prevent Blindness, New York, NY: Visual Sciences Core Grant EY020799, NIH CTSA Grant UL1TR001105 and CTSA NIH Grant UL1-RR024982.
Publisher Copyright:
© 2021 Kim et al.
PY - 2021
Y1 - 2021
N2 - Background: Medication adherence in glaucoma patients remains sub-par despite proven benefits of regular administration. The objective was to analyze medication adherence before and after lifestyle counseling in patients with ocular hypertension (OHT) or primary open-angle glaucoma (POAG) (mild, moderate, severe). Methods: Prospective cohort study from May to July 2018 at a single academic center. From 391 consecutive records, 247 were excluded based on exclusion criteria with 28 patients not meeting inclusion criteria resulting in the final sample of 116 patients (33 had OHT, 83 had POAG – 28 mild, 39 moderate, 16 severe). Scripted lifestyle counseling focusing on diet, exercise, vitamin intake, stress management, and medication adherence was administered by a team of trained medical students. Primary outcome measure was self-reported medication adherence, defined as not missing an eye drop administration in the past month. A 2–3 week follow-up with scripted telephone survey assessing medication adherence, diet, and exercise was collected. Results: At baseline, in 116 patients, 59.5% were adherent to their medication with a breakdown of 42.4% OHT, 64.3% mild, 66.7% moderate, and 68.7% severe and an increasing trend in medication adherence was found across increasing disease severity (p=0.055). Of the 76 (65.5%) patients reached for follow-up, 17 (22.4%) became adherent following lifestyle counseling (p=0.02) increasing overall adherence to 78.9% from 62.5%. Conclusion: In our study, comprehensive lifestyle counseling succeeded in increasing medication adherence in patients with OHT and POAG.
AB - Background: Medication adherence in glaucoma patients remains sub-par despite proven benefits of regular administration. The objective was to analyze medication adherence before and after lifestyle counseling in patients with ocular hypertension (OHT) or primary open-angle glaucoma (POAG) (mild, moderate, severe). Methods: Prospective cohort study from May to July 2018 at a single academic center. From 391 consecutive records, 247 were excluded based on exclusion criteria with 28 patients not meeting inclusion criteria resulting in the final sample of 116 patients (33 had OHT, 83 had POAG – 28 mild, 39 moderate, 16 severe). Scripted lifestyle counseling focusing on diet, exercise, vitamin intake, stress management, and medication adherence was administered by a team of trained medical students. Primary outcome measure was self-reported medication adherence, defined as not missing an eye drop administration in the past month. A 2–3 week follow-up with scripted telephone survey assessing medication adherence, diet, and exercise was collected. Results: At baseline, in 116 patients, 59.5% were adherent to their medication with a breakdown of 42.4% OHT, 64.3% mild, 66.7% moderate, and 68.7% severe and an increasing trend in medication adherence was found across increasing disease severity (p=0.055). Of the 76 (65.5%) patients reached for follow-up, 17 (22.4%) became adherent following lifestyle counseling (p=0.02) increasing overall adherence to 78.9% from 62.5%. Conclusion: In our study, comprehensive lifestyle counseling succeeded in increasing medication adherence in patients with OHT and POAG.
KW - Glaucoma
KW - Lifestyle counseling
KW - Medication adherence
UR - http://www.scopus.com/inward/record.url?scp=85113672998&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85113672998&partnerID=8YFLogxK
U2 - 10.2147/OPTH.S321351
DO - 10.2147/OPTH.S321351
M3 - Article
C2 - 34429583
AN - SCOPUS:85113672998
SN - 1177-5467
VL - 15
SP - 3521
EP - 3529
JO - Clinical Ophthalmology
JF - Clinical Ophthalmology
ER -